All Studies | Orsiro

Clinical study overview*

Study Name Study Type Patients Status Primary Endpoint
BIOSTEMI RCT 1300 24-month FU available TLF at 24 months
Taglieri et al. Network Meta-Analysis 99039 - TLF at 12 months and the longest FU available
BIOFLOW-V RCT 1334 36-month FU available TLF at 12 months
BIO-RESORT RCT 3514 36-month FU available TVF at 12 months
BIONYX RCT 2488 24-month FU available TVF at 12 months
BIOSCIENCE RCT 2119 Completed, 60-month FU available TLF at 12 months
TICO RCT 3056 Completed, primary endpoint reached NACE at 12 months
SMART-CHOICE RCT 3000 Primary endpoint reached MACCE at 12 months
SCAAR All comers registry 69570 24-month FU available -
SORT OUT VII RCT 2525 36-month FU available TLF at 12 months
SORT OUT IX RCT 3151 12-month FU available TLF at 12 months
BIODEGRADE RCT 3850 Primary endpoint reached TLF at 18 months
BIOFLOW-III Single arm registry 1356 Completed, 60-month FU available TLF at 12 months
BIOFLOW-IV RCT 575 Completed, 60-month FU available TVF at 12 months
BIOFLOW-VI RCT 440 12-month FU available LLL at 9 months
HEROES Single arm registry 353 Primary endpoint reached DOCE at 12 months
ROSES Single arm registry 460 Preliminary results available TLF at 12 months
ORIENT RCT 372 Primary endpoint reached LLL at 9 months
Hattrick-OCT
RCT 44 Primary endpoint reached Strut coverage at 3 months
ISAR OCT RCT 39 Primary endpoint reached Strut coverage at 6 months
PRISON-IV RCT 330 Primary endpoint reached LLL at 9 months
PREPARE-CALC RCT 200 Completed Strategy success and LLL at 9 months
BIOFLOW-I
FIM 30 Completed, 12-month FU available LLL at 9 months
BIOFLOW-II RCT 452 Completed, 60-month FU available LLL at 9 months
BIOLUX-RCT RCT 210 12-month FU available LLL at 6 months
REVELATION RCT 120 Primary endpoint reached FFR at 9 months

*a selection of the full clinical program of the Orsiro family.

Are you interested in specific study data?

CONTACT US